Cambridge Launches Multidisciplinary Synthetic Bio, Big Data Initiatives | GenomeWeb

NEW YORK (GenomeWeb News) – The University of Cambridge said today it has launched new multidisciplinary, collaborative research programs focused on synthetic biology and big data, as well as cardiovascular disease and public policy.

The university has added the four new subject areas into its Strategic Research Initiative program, which brings together academics from different disciplines to harness their expertise and make a “real-world impact,” Cambridge said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.